发明名称 Anvendelse af 2-Alpha-Cyano-4-Alpha, 5-Alpha-epoxyandrostan-17-Beta-OL-3-ON-derivater til sænkning af niveauer af serumcortisol og til behandling af dermed forbundne kliniske tilstande
摘要 <p>Use of a compound of formula (I) or a 3-enol C1-4 alkanoate ester thereof in the manufacture of a medicament for the intermittent treatment of a condition of a human or non-human mammal in which sail mammal has a abnormally high serum concentration of an adrenal hormone: Wherein R1, R2, R5, and R6 are the same or different and each is hydrogen or C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00001"/>1 to 4? alkyl; R3 is hydrogen C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00002"/>1 to 4? alkyl, C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00003"/>1 to 4? alkenyl or C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00004"/>1 to 4? alkynyl; R4is hydroxy, C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00005"/>1 to 4? alkanoyloxy, a group of formula (II) or (III) Wherein R7 is (CH2)n, where n is an integer of from 0 to 4, R8 is hydrogen, C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00006"/>1 to 4? alkyl, hydroxy or NH2 and R9 and R10 are the same or different and each is hydrogen or C<custom-character file="US20040204392A1-20041014-P00900.TIF" wi="20" he="20" id="custom-character-00007"/>1 to 4? Alkyl; or R3 and R4 together are oxo, ethylenedioxy or propylenedioxy. The invention has practical benefits for the treatment of man and other animals with diseases associated with abnormal production of adrenal steroids. The invention also shows that sustained suppression of the adrenal hormones is not required to achieve relief of symptoms in these conditions.</p>
申请公布号 DK1385527(T3) 申请公布日期 2007.10.29
申请号 DK20020708546T 申请日期 2002.04.09
申请人 STEGRAM PHARMACEUTICALS LIMITED 发明人 WOOD, CHRISTOPHER;MARGETTS, GEORGE
分类号 A61K31/56;A61K31/57;A61K31/575;A61K31/58;A61P5/08;A61P5/42;A61P5/46;A61P13/12;A61P17/14;A61P29/00;C07J71/00 主分类号 A61K31/56
代理机构 代理人
主权项
地址